On The Cannabis Boomer's News and Reviews for October 15, 2025. the Cannabis Boomer reviews news on the Trump Administration's possible rescheduling of cannabis to a DEA level 3 substance, and covers three new publications in cannabis science. The Cannabis Boomer Podcast is not only for older adults and baby boomers, but for all adults interested in the science of cannabis and health.
On today's Cannabis Boomer's Journal of News and Reviews in Cannabis Science, Dr. Alex Terrazas PhD gives his take on the latest findings in cannabis research.
But first. here is The Cannabis Boomer's top cannabis news story.
[0:0:18.69] The Cannabis Boomer
,:
The article discusses the uncertainty surrounding the potential rescheduling of marijuana under the Trump administration. While President Trump has expressed some support for medical marijuana and states' rights, he has not made rescheduling a priority. His key advisors, including the Secretary of Health and Human Services, DEA Administrator, and Attorney General, have also been hesitant to take a firm stance on the issue. Additionally, Congress has shown little appetite for marijuana reform, despite widespread public support. The author concludes that he does not have confidence the federal government will reschedule marijuana in the short term, and even if it does, the market cannot predict how the government will treat marijuana differently. Overall, the article paints a picture of persistent uncertainty around the future of marijuana rescheduling under the Trump administration.
[0:1:22.17] Grace
And now the Cannabis Boomer reviews recent cannabis science publications.
[0:1:27.66] The Cannabis Boomer
The first article I am covering is Pain, Depression, and Functional Outcomes Among Older Adults Who Use Cannabis or Opioid Analgesics for Chronic Pain Conditions by Aebischer et al. This study examined the use of cannabis and prescription opioids among older adults with chronic, non-cancer pain, and their associated pain, function, and depression outcomes over time. Here is what I found interesting. Older adults with CNCP who used cannabis had lower pain and depression scores, and better functional outcomes compared to those using prescription opioids. This was a longitudinal observational study that followed older adults with CNCP over time, assessing their use of cannabis or prescription opioids, as well as measures of pain, function, and depression. The findings suggest that cannabis may be a viable alternative to prescription opioids for the management of chronic pain in older adults, with potential benefits for pain, function, and mental health. The results are interesting but keep in mind that the study was observational, and did not include a control group of older adults with CNCP who did not use either cannabis or opioids, limiting the ability to draw causal conclusions.
Next up: Doctors' and pharmacists' perspectives on the clinical use of medicinal Cannabis: a cross-sectional study by Zammit Dimech, & Grech. This cross-sectional study examined the perspectives of doctors and pharmacists in Malta on the clinical use of medicinal cannabis. Here is what I found interesting. Healthcare professionals' attitudes, beliefs, and knowledge regarding medicinal cannabis remain variable, and perceived barriers to clinical integration were identified. A cross-sectional study was conducted to assess healthcare professionals' perspectives on the clinical use of medicinal cannabis. The findings highlight the need for improved education and training for healthcare professionals to facilitate the integration of medicinal cannabis into clinical practice. Some methodological challenges are that the study was limited to a single country, and the cross-sectional design may not capture the evolving nature of healthcare professionals' perspectives on medicinal cannabis.
The final article today is Should cannabis be used in the management of endometriosis? by Armour and colleagues. Here is my take. This research article explores the potential use of cannabis in the management of endometriosis, a chronic inflammatory condition affecting women of reproductive age. Here are the main findings. Cross-sectional and retrospective data suggest that people with endometriosis are using cannabis to help manage their symptoms, which current medical treatments tend to be sub-optimal in addressing. The article does not provide details on the specific methods used, as it is a review of existing cross-sectional and retrospective data. The findings suggest that cannabis may be a potential alternative or complementary treatment option for managing the symptoms of endometriosis, which could improve patient satisfaction with current medical treatments. Some methodological challenges are that The article does not provide any information on the methodological shortcomings of the cross-sectional and retrospective data it reviews, as it is a narrative review rather than a systematic analysis of the existing literature.
[0:5:19.05] Michael
You've been listening to The Cannabis Boomer's Journal of News and Reviews in Cannabis Science. The Cannabis Boomer Podcast is not just for baby boomers and older adults but for all adults who are interested in the science of cannabis and health. Join the Cannabis Boomer daily for these concise scientific reviews and visit The Cannabis Boomer Podcast for in-depth looks and interviews.
